Larissa Dirr

407 total citations
18 papers, 289 citations indexed

About

Larissa Dirr is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Larissa Dirr has authored 18 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 8 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Larissa Dirr's work include Respiratory viral infections research (12 papers), Influenza Virus Research Studies (5 papers) and Virology and Viral Diseases (5 papers). Larissa Dirr is often cited by papers focused on Respiratory viral infections research (12 papers), Influenza Virus Research Studies (5 papers) and Virology and Viral Diseases (5 papers). Larissa Dirr collaborates with scholars based in Australia, Germany and United States. Larissa Dirr's co-authors include Mark von Itzstein, Patrice Guillon, Benjamin Bailly, Ibrahim M. El‐Deeb, Thomas Haselhorst, Leonard M. G. Chavas, Robin J. Thomson, Belinda L. Spillings, Freda E.‐C. Jen and Michael P. Jennings and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Chemical Communications.

In The Last Decade

Larissa Dirr

16 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larissa Dirr Australia 12 155 133 83 53 27 18 289
Kenny Simmen Belgium 7 96 0.6× 99 0.7× 99 1.2× 121 2.3× 20 0.7× 8 327
Benjamin Bailly Australia 13 158 1.0× 154 1.2× 112 1.3× 40 0.8× 40 1.5× 20 380
Christophe Buyck Belgium 8 78 0.5× 136 1.0× 157 1.9× 32 0.6× 29 1.1× 15 356
Annette von Delft United Kingdom 9 92 0.6× 75 0.6× 74 0.9× 15 0.3× 35 1.3× 15 252
Jérôme Deval United States 8 118 0.8× 237 1.8× 146 1.8× 35 0.7× 30 1.1× 13 402
Takanori Tomozawa Japan 6 283 1.8× 54 0.4× 127 1.5× 62 1.2× 48 1.8× 9 350
Navisha Dookie South Africa 9 249 1.6× 316 2.4× 110 1.3× 23 0.4× 17 0.6× 13 409
Dawn D. Parker United States 13 134 0.9× 203 1.5× 154 1.9× 137 2.6× 35 1.3× 22 498
Anushka V. Devnikar India 4 54 0.3× 109 0.8× 45 0.5× 16 0.3× 16 0.6× 5 216
Juan Ignacio García United States 9 146 0.9× 222 1.7× 103 1.2× 26 0.5× 16 0.6× 20 302

Countries citing papers authored by Larissa Dirr

Since Specialization
Citations

This map shows the geographic impact of Larissa Dirr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larissa Dirr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larissa Dirr more than expected).

Fields of papers citing papers by Larissa Dirr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larissa Dirr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larissa Dirr. The network helps show where Larissa Dirr may publish in the future.

Co-authorship network of co-authors of Larissa Dirr

This figure shows the co-authorship network connecting the top 25 collaborators of Larissa Dirr. A scholar is included among the top collaborators of Larissa Dirr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larissa Dirr. Larissa Dirr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Dirr, Larissa, Ling‐Hui Li, Thomas Ve, et al.. (2024). Tetramerization is essential for the enzymatic function of the Pseudomonas aeruginosa virulence factor UDP-glucose pyrophosphorylase. mBio. 15(4). e0211423–e0211423. 1 indexed citations
2.
Bailly, Benjamin, et al.. (2024). Novel insights into the host cell glycan binding profile of human metapneumovirus. Journal of Virology. 98(6). e0164123–e0164123. 11 indexed citations
5.
Guillon, Patrice, et al.. (2022). Drug Repurposing for Therapeutic Discovery against Human Metapneumovirus Infection. Antimicrobial Agents and Chemotherapy. 66(10). e0100822–e0100822. 9 indexed citations
6.
Bailly, Benjamin, et al.. (2022). Antiviral strategies against human metapneumovirus: Targeting the fusion protein. Antiviral Research. 207. 105405–105405. 23 indexed citations
7.
Sreejith, Kamalalayam Rajan, Muhammad Umer, Larissa Dirr, et al.. (2021). A Portable Device for LAMP Based Detection of SARS-CoV-2. Micromachines. 12(10). 1151–1151. 16 indexed citations
8.
9.
Bailly, Benjamin, Anil K. Gorle, Larissa Dirr, et al.. (2021). Platinum complexes act as shielding agents against virus infection. Chemical Communications. 57(38). 4666–4669. 16 indexed citations
10.
Dirr, Larissa, et al.. (2019). Targeting Human Parainfluenza Virus Type-1 Haemagglutinin-Neuraminidase with Mechanism-Based Inhibitors. Viruses. 11(5). 417–417. 4 indexed citations
11.
Dirr, Larissa, Patrice Guillon, Ibrahim M. El‐Deeb, et al.. (2019). New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase. Antiviral Research. 167. 89–97. 25 indexed citations
12.
Li, Linghui, Benjamin Bailly, Andrea Maggioni, et al.. (2018). A Sulfonozanamivir Analogue Has Potent Anti‐influenza Virus Activity. ChemMedChem. 13(8). 785–789. 14 indexed citations
13.
Dirr, Larissa, et al.. (2018). Structural Insights into Human Parainfluenza Virus 3 Hemagglutinin–Neuraminidase Using Unsaturated 3-N-Substituted Sialic Acids as Probes. ACS Chemical Biology. 13(6). 1544–1550. 13 indexed citations
14.
Dirr, Larissa, Ibrahim M. El‐Deeb, Leonard M. G. Chavas, Patrice Guillon, & Mark von Itzstein. (2017). The impact of the butterfly effect on human parainfluenza virus haemagglutinin-neuraminidase inhibitor design. Scientific Reports. 7(1). 4507–4507. 12 indexed citations
15.
Bailly, Benjamin, Larissa Dirr, Ibrahim M. El‐Deeb, et al.. (2016). A dual drug regimen synergistically blocks human parainfluenza virus infection. Scientific Reports. 6(1). 24138–24138. 18 indexed citations
16.
El‐Deeb, Ibrahim M., Patrice Guillon, Larissa Dirr, & Mark von Itzstein. (2016). Exploring inhibitor structural features required to engage the 216-loop of human parainfluenza virus type-3 hemagglutinin-neuraminidase. MedChemComm. 8(1). 130–134. 7 indexed citations
17.
Dirr, Larissa, et al.. (2015). The Catalytic Mechanism of Human Parainfluenza Virus Type 3 Haemagglutinin‐Neuraminidase Revealed. Angewandte Chemie International Edition. 54(10). 2936–2940. 26 indexed citations
18.
Guillon, Patrice, Larissa Dirr, Ibrahim M. El‐Deeb, et al.. (2014). Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin–neuraminidase inhibitors. Nature Communications. 5(1). 5268–5268. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026